Results 21 to 30 of about 19,811 (179)
Management of carbapenem-resistant Enterobacteriaceae infections [PDF]
Clinical Microbiology and Infection, 2019 Carbapenem resistance is defined as in vitro non-susceptibility to any carbapenem and/or documented production of a carbapenemase. This feature has rapidly spread worldwide among clinical isolates of Enterobacteriaceae, mostly Klebsiella spp., and is associated with diverse molecular mechanisms. Carbapenem resistance is often associated with resistance
Durante-Mangoni, Emanuele +2 more
openaire +3 more sources
Carbapenem and colistin resistance in children with Enterobacteriaceae infections
The Turkish Journal of Pediatrics, 2020 Background. Carbapenem-resistant Enterobacteriaceae (CRE) are an emerging global public health threat. As a reserve agent, colistin has been the drug of choice for the treatment of infections caused by CRE.
Zeliha Haytoğlu +5 more
doaj +1 more source
Carbapenem-Resistant Enterobacteriaceae Infections in Children [PDF]
Current Infectious Disease Reports, 2015 Carbapenem-resistant Enterobacteriaceae (CRE) are an emerging global public health threat. Infections due to CRE are associated with significant morbidity and mortality. Few therapeutic options are available for treatment of these infections, and optimal antibiotic treatment regimens are unclear.
Kathleen, Chiotos +2 more
openaire +2 more sources
Carbapenem-Resistant Enterobacteriaceae: Epidemiology and Prevention [PDF]
Clinical Infectious Diseases, 2011 Over the past 10 years, dissemination of Klebsiella pneumoniae carbapenemase (KPC) has led to an increase in the prevalence of carbapenem-resistant Enterobacteriaceae (CRE) in the United States. Infections caused by CRE have limited treatment options and have been associated with high mortality rates. In the previous year, other carbapenemase subtypes,
Neil, Gupta +3 more
openaire +2 more sources
blaKPC gene Detection in Clinical Isolates of Carbapenem Resistant Enterobacteriaceae in a Tertiary Care Hospital [PDF]
Journal of Clinical and Diagnostic Research, 2013 Introduction: Carbapenem resistance among Enterobacteriaceae, especially in Klebsiella pneumoniae and Escherichia coli, is an emerging problem worldwide.
Priyadarshini Shanmugam +2 more
doaj +1 more source
Environmental Contamination by Carbapenem-Resistant Enterobacteriaceae [PDF]
Journal of Clinical Microbiology, 2013 ABSTRACT In the last decade, the global emergence of carbapenem resistance in Enterobacteriaceae has posed great concern to public health. Data concerning the role of environmental contamination in the dissemination of carbapenem-resistant Enterobacteriaceae (CRE) are currently ...
Lerner, A. +5 more
openaire +2 more sources
Journal of Rawalpindi Medical College, 2022 Objective: The objective of the study was to determine the frequency and antimicrobial susceptibility pattern of Carbapenem-Resistant Enterobacteriaceae among clinical isolates in Karachi, Pakistan.
Faisal Iqbal Afridi, Saeeda Baig, Aliya Irshad Sani, Qamar Jamal
doaj +1 more source
A review on bacterial resistance to carbapenems: epidemiology, detection and treatment options
Future Science OA, 2020 Carbapenems are a class of antimicrobial agents reserved for infections caused by multidrug-resistant microorganisms. The emergence of carbapenem resistance has become a serious public health threat.
Ann A Elshamy, Khaled M Aboshanab
doaj +1 more source
Detection of plasmid-mediated colistin-resistant and carbapenem-resistant genes by multiplex PCR
MethodsX, 2018 A multiplex PCR was described to simultaneously detect mcr-1 and frequently occurring carbapenem-resistant genes including blaKPC, blaNDM, blaIMP, and blaOXA-48-like in a single reaction.
Rujirat Hatrongjit +3 more
doaj +1 more source
Prevalence of carbapenem resistant Enterobacteriaceae from a tertiary care hospital in Mumbai, India [PDF]
Journal of Microbiology and Infectious Diseases, 2013 Objective: The emergence of Carbapenem Resistant Enterobacteriaceae (CRE) in recent times has become a serious threat to public health due to the high mortality, potential dissemination rates and limited treatment options associated with these ...
Pravin K. Nair, Michelle S Vaz
doaj +1 more source